Yael Levy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Yael Levy has a total of 129 co-authors. Here are the top co-authors by number of shared publications:
- Jérôme Allyn
Intensive care unit, Saint-Denis University Hospital, Saint-Denis, Reunion Island, France
3 shared publications - Nicolas Allou
Réanimation polyvalente, Centre Hospitalier Universitaire Félix Guyon, Saint Denis, France
3 shared publications - Alban-Elouen Baruteau
Nantes Université
2 shared publications - Dorothée Valance
Réanimation Polyvalente, Centre Hospitalier Universitaire Félix Guyon, Saint-Denis, France
2 shared publications - Gerald Laforest
Department of Pediatric Cardiology (G.L., J.-B.S.), CHU La Réunion, Saint-Denis, France
2 shared publications Jean Ripoche
Université de Bordeaux, 33000 Bordeaux, France; Bioingénierie Tissulaire, U1026, INSERM, 33000 Bordeaux, France
2 shared publications
Latest Publications
- 1 April 2026
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 19 (4) , e016293
Tele-Proctoring for Device Closure of Patent Ductus Arteriosus in Extremely Low-Birth-Weight Infants
- 1 April 2026
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 19 (4) , e016293
Tele-Proctoring for Device Closure of Patent Ductus Arteriosus in Extremely Low-Birth-Weight Infants
- 9 September 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 62 (suppl 67) , PA2129
Lung biopsies in infants and children in critical care situation
Introduction: Lung biopsy is the gold standard for the diagnosis of diffuse lung diseases. Its indication has to be balanced with its invasiveness. The present study aims at identifying the best indications of lung biopsies in pediatric patients hospitalized in intensive care unit (ICU). Methods: Children hospitalized in ICU who underwent a lung biopsy were included between 1995 and 2022. Biopsies performed in the operating room, post-mortem biopsies and autopsies were excluded. Results: Thirty-one patients were included at a median age of 18 days (2 days to 10.8 years); 21 (67.7%) were newborns. All had an invasive ventilation, 26 (89.7%) had a pulmonary hypertension and 22 (70.9%) were under extra corporeal membrane oxygenation (ECMO). The lung biopsy allowed a diagnosis in 81% of the patients, diagnostic reliability decreasing with age (95%, 71% and 0% in newborns, 1 month to 2 years and > 2 years-old respectively). Diffuse developmental disorders of the lung represented 15 (48%) patients, mostly alveolar capillary dysplasia, followed by surfactant disorders in 5 (16%) patients. Complications occurred in 9 (39.1%) patients including 8 under ECMO with massive hemorrhages in 7 cases. A duration of ECMO ≥ 10 days and an age > 2 years-old seemed to be of higher risk of complications. Conclusion: Lung biopsy is a reliable exploration in neonates in critical situation in whom a diffuse developmental disorder of the lung is suspected. In older children, the risk of the procedure increases while its diagnostic reliability decreases. Very few therapeutic modifications followed the lung biopsy; however it allowed withdrawing ECMO and other high levels of life-sustaining supports in fatal forms of congenital diseases.
- 9 September 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 62 (suppl 67) , PA2129
Lung biopsies in infants and children in critical care situation
Introduction: Lung biopsy is the gold standard for the diagnosis of diffuse lung diseases. Its indication has to be balanced with its invasiveness. The present study aims at identifying the best indications of lung biopsies in pediatric patients hospitalized in intensive care unit (ICU). Methods: Children hospitalized in ICU who underwent a lung biopsy were included between 1995 and 2022. Biopsies performed in the operating room, post-mortem biopsies and autopsies were excluded. Results: Thirty-one patients were included at a median age of 18 days (2 days to 10.8 years); 21 (67.7%) were newborns. All had an invasive ventilation, 26 (89.7%) had a pulmonary hypertension and 22 (70.9%) were under extra corporeal membrane oxygenation (ECMO). The lung biopsy allowed a diagnosis in 81% of the patients, diagnostic reliability decreasing with age (95%, 71% and 0% in newborns, 1 month to 2 years and > 2 years-old respectively). Diffuse developmental disorders of the lung represented 15 (48%) patients, mostly alveolar capillary dysplasia, followed by surfactant disorders in 5 (16%) patients. Complications occurred in 9 (39.1%) patients including 8 under ECMO with massive hemorrhages in 7 cases. A duration of ECMO ≥ 10 days and an age > 2 years-old seemed to be of higher risk of complications. Conclusion: Lung biopsy is a reliable exploration in neonates in critical situation in whom a diffuse developmental disorder of the lung is suspected. In older children, the risk of the procedure increases while its diagnostic reliability decreases. Very few therapeutic modifications followed the lung biopsy; however it allowed withdrawing ECMO and other high levels of life-sustaining supports in fatal forms of congenital diseases.
- Open Access
- 14 July 2023
- Published by Springer Nature in Intensive Care Medicine – Paediatric and Neonatal
- Vol. 1 (1) , 1-8
Halogenated volatile anaesthetics for prolonged sedation in pediatric intensive care unit: first experience in two French pediatric intensive care units
Objective: Sedation is necessary for patients to achieve comfort and safety, but prolonged sedation can lead to the need for increased doses, resulting in withdrawal syndrome and delayed extubation. Inhaled anaesthetics (IAs) may cause less withdrawal syndrome while providing similar sedative effects to intravenous agents. This study aims to describe the efficacy of halogenated IAs during prolonged sedation and identify any adverse effects on the PICU. Design: This is a retrospective, bicentric cohort study. Setting: The study was conducted at two PICUs in university hospitals in Paris between January 2018 and December 2020. Patients: The study included 50 children (aged 2.2 years, [0.8–7.2]) who received prolonged sedation (> 72 h) and were sedated with volatile anaesthetics for at least 24 h. Interventions: No interventions were performed. Measurements and main results: The study found a statistically significant reduction in benzodiazepine dosages (μg/kg/h) (118 [62.5; 200] vs 80.0 [32.5; 120], p < 0.01). Similar results were observed for other hypnotics (ketamine 2.00 [1.00; 2.00] vs 1.50 [1.00; 2.00], p = 0.036, mg/kg/h; clonidine: 0.55 [0.35; 1.27] vs 0.20 [0.12; 0.43], p = 0.036, μg/kg/h). For opioids (μg/kg/h), no significant reduction in doses was observed 24 h after IA introduction (4 [1.00; 8.00] vs 4.00 [1.00; 6.70], p = 0.7). No major adverse effects were reported, although 26% of patients developed withdrawal syndrome. Conclusions: Halogenated IAs appear to be a promising therapy to reduce the dosages of hypnotics and opioids used during prolonged sedations.
- 14 July 2023
- Published by Springer Nature in Intensive Care Medicine – Paediatric and Neonatal
- Vol. 1 (1) , 1-8
Open AccessHalogenated volatile anaesthetics for prolonged sedation in pediatric intensive care unit: first experience in two French pediatric intensive care units
Objective: Sedation is necessary for patients to achieve comfort and safety, but prolonged sedation can lead to the need for increased doses, resulting in withdrawal syndrome and delayed extubation. Inhaled anaesthetics (IAs) may cause less withdrawal syndrome while providing similar sedative effects to intravenous agents. This study aims to describe the efficacy of halogenated IAs during prolonged sedation and identify any adverse effects on the PICU. Design: This is a retrospective, bicentric cohort study. Setting: The study was conducted at two PICUs in university hospitals in Paris between January 2018 and December 2020. Patients: The study included 50 children (aged 2.2 years, [0.8–7.2]) who received prolonged sedation (> 72 h) and were sedated with volatile anaesthetics for at least 24 h. Interventions: No interventions were performed. Measurements and main results: The study found a statistically significant reduction in benzodiazepine dosages (μg/kg/h) (118 [62.5; 200] vs 80.0 [32.5; 120], p < 0.01). Similar results were observed for other hypnotics (ketamine 2.00 [1.00; 2.00] vs 1.50 [1.00; 2.00], p = 0.036, mg/kg/h; clonidine: 0.55 [0.35; 1.27] vs 0.20 [0.12; 0.43], p = 0.036, μg/kg/h). For opioids (μg/kg/h), no significant reduction in doses was observed 24 h after IA introduction (4 [1.00; 8.00] vs 4.00 [1.00; 6.70], p = 0.7). No major adverse effects were reported, although 26% of patients developed withdrawal syndrome. Conclusions: Halogenated IAs appear to be a promising therapy to reduce the dosages of hypnotics and opioids used during prolonged sedations.
- Open Access
- 20 June 2022
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 26 (6) , 745-747
First Case of Acute Myocarditis Caused by Metapneumovirus in an Immunocompromised 14-year-old Girl
Background: Human metapneumovirus (hMPV) is a paramyxovirus, well known as a causative agent of respiratory tract infections. Non-respiratory manifestations, including cardiac impairments, remain rare. Only two cases of myocarditis caused by hMPV have been described in adults. Case description: We present the case of a 14-year-old female suffering from Burkitt leukemia and diagnosed with severe myocarditis caused by hMPV, based on results from real-time polymerase chain reaction (RT- PCR) and magnetic resonance imaging (MRI). She was successfully treated by venoarterial extracorporeal membrane oxygenation and intravenous immunoglobulins. She was discharged from pediatric intensive care unit (PICU) 3 weeks later. Conclusion: This is the first pediatric case of hMPV myocarditis requiring venoarterial extracorporeal membrane oxygenation.
- 20 June 2022
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 26 (6) , 745-747
Open AccessFirst Case of Acute Myocarditis Caused by Metapneumovirus in an Immunocompromised 14-year-old Girl
Background: Human metapneumovirus (hMPV) is a paramyxovirus, well known as a causative agent of respiratory tract infections. Non-respiratory manifestations, including cardiac impairments, remain rare. Only two cases of myocarditis caused by hMPV have been described in adults. Case description: We present the case of a 14-year-old female suffering from Burkitt leukemia and diagnosed with severe myocarditis caused by hMPV, based on results from real-time polymerase chain reaction (RT- PCR) and magnetic resonance imaging (MRI). She was successfully treated by venoarterial extracorporeal membrane oxygenation and intravenous immunoglobulins. She was discharged from pediatric intensive care unit (PICU) 3 weeks later. Conclusion: This is the first pediatric case of hMPV myocarditis requiring venoarterial extracorporeal membrane oxygenation.
- Open Access
- 20 May 2022
- Published by Springer Nature in Critical Care
- Vol. 26 (1) , 1-3
Hidden Harlequin syndrome in neonatal and pediatric VA-ECMO
- 20 May 2022
- Published by Springer Nature in Critical Care
- Vol. 26 (1) , 1-3
Open AccessHidden Harlequin syndrome in neonatal and pediatric VA-ECMO
- 9 February 2022
- Published by Wiley in Acta Paediatrica
- Vol. 111 (5) , 971-978
Utilisation of neonatologist‐performed echocardiography in shock among neonatologists with interest in haemodynamic: International survey
Aim Neonatologist-performed echocardiography (NPE) is recommended during shock. We aimed to assess factors associated with NPE utilization in the NICU and physiological information obtained during management of shock. Methods An internet-based survey, sent to neonatologists with interest in hemodynamics, studying NPE utilization in shock management through a real clinical case and correlating its use with responders’ training and NICU settings. Results 59 completed surveys were received from the United-Kingdom: 38%, Western Europe: 32%, Canada: 23% and other countries: 7%. While managing the given clinical case, 90% of responders expected first NPE to exclude congenital heart disease - although only 61% could exclude it confidently (71% in trained clinicians vs. 29% without training; p<0.01). NPE utilization prior to initiate treatment was significantly correlated with mean number of neonatologists able to perform NPE in the NICU (4.9 vs. 2.9 neonatologists per unit; p=0.02). Similarly, for ongoing therapeutic guidance, NPE was more used in trained clinicians (p<0.01). 88% and 81% of responders studied a combination of multiple parameters to assess filling and systemic flow respectively. Conclusion NPE during shock management differs with previous training and number of doctors able to perform echocardiography in NICU. This study highlighted the need for enhanced training implementation.
- 9 February 2022
- Published by Wiley in Acta Paediatrica
- Vol. 111 (5) , 971-978
Utilisation of neonatologist‐performed echocardiography in shock among neonatologists with interest in haemodynamic: International survey
Aim Neonatologist-performed echocardiography (NPE) is recommended during shock. We aimed to assess factors associated with NPE utilization in the NICU and physiological information obtained during management of shock. Methods An internet-based survey, sent to neonatologists with interest in hemodynamics, studying NPE utilization in shock management through a real clinical case and correlating its use with responders’ training and NICU settings. Results 59 completed surveys were received from the United-Kingdom: 38%, Western Europe: 32%, Canada: 23% and other countries: 7%. While managing the given clinical case, 90% of responders expected first NPE to exclude congenital heart disease - although only 61% could exclude it confidently (71% in trained clinicians vs. 29% without training; p<0.01). NPE utilization prior to initiate treatment was significantly correlated with mean number of neonatologists able to perform NPE in the NICU (4.9 vs. 2.9 neonatologists per unit; p=0.02). Similarly, for ongoing therapeutic guidance, NPE was more used in trained clinicians (p<0.01). 88% and 81% of responders studied a combination of multiple parameters to assess filling and systemic flow respectively. Conclusion NPE during shock management differs with previous training and number of doctors able to perform echocardiography in NICU. This study highlighted the need for enhanced training implementation.
- Open Access
Antenatal Diagnosis of a Partial Atrioventricular Canal with Ebstein’s Anomaly
The simultaneous occurrence of an atrioventricular canal defect (AVCD) and Ebstein’s anomaly is extremely rare, occurring in less than 0.5% of all patients with AVCD. Only 22 cases are described in the literature. This patient’s antenatal diagnosis of both Ebstein’s anomaly and partial AVCD was made at 25 weeks of gestation. The delivery was organized in a tertiary center. The initial neonatal course was difficult but with adequate treatment, a rapid improvement allowed for a gap of almost 2 years before a complete surgical repair including a cone tricuspid plasty. To our knowledge, this is the first case of antenatal diagnosis, with carefully tailored delivery, neonatal care and subsequent follow-up before indication for successful surgery.
Open AccessAntenatal Diagnosis of a Partial Atrioventricular Canal with Ebstein’s Anomaly
The simultaneous occurrence of an atrioventricular canal defect (AVCD) and Ebstein’s anomaly is extremely rare, occurring in less than 0.5% of all patients with AVCD. Only 22 cases are described in the literature. This patient’s antenatal diagnosis of both Ebstein’s anomaly and partial AVCD was made at 25 weeks of gestation. The delivery was organized in a tertiary center. The initial neonatal course was difficult but with adequate treatment, a rapid improvement allowed for a gap of almost 2 years before a complete surgical repair including a cone tricuspid plasty. To our knowledge, this is the first case of antenatal diagnosis, with carefully tailored delivery, neonatal care and subsequent follow-up before indication for successful surgery.
- 3 February 2021
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 104 (2) , 739-743
Case Report: Emergence of Candida auris in the Indian Ocean Region
Candida auris is an emerging multidrug-resistant yeast that can cause severe infections and spread easily between hospitalized patients, leading to outbreaks in hospital. Here, we report the first four cases of colonization and invasive infection with C. auris reported in the Indian Ocean region. All cases were observed in the French overseas Reunion Island, a very popular destination for European travelers. Three patients had urinary tract or skin colonization, and one had a fatal invasive infection. In three cases, including that of the infected patient, the yeast was not initially identified as C. auris, preventing specific hygiene measures to be implemented as suggested in the December 2016 clinical alert to European healthcare facilities. The infected patient likely acquired C. auris in the intensive care unit from the first colonized patient. This is the first case of C. auris infection and the first potential case of nosocomial transmission of the pathogen to be reported in the French overseas Reunion Island.
- 3 February 2021
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 104 (2) , 739-743
Case Report: Emergence of Candida auris in the Indian Ocean Region
Candida auris is an emerging multidrug-resistant yeast that can cause severe infections and spread easily between hospitalized patients, leading to outbreaks in hospital. Here, we report the first four cases of colonization and invasive infection with C. auris reported in the Indian Ocean region. All cases were observed in the French overseas Reunion Island, a very popular destination for European travelers. Three patients had urinary tract or skin colonization, and one had a fatal invasive infection. In three cases, including that of the infected patient, the yeast was not initially identified as C. auris, preventing specific hygiene measures to be implemented as suggested in the December 2016 clinical alert to European healthcare facilities. The infected patient likely acquired C. auris in the intensive care unit from the first colonized patient. This is the first case of C. auris infection and the first potential case of nosocomial transmission of the pathogen to be reported in the French overseas Reunion Island.
- 3 February 2021
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 104 (2) , 552-556
Case Report: Refractory Shock due to Fulminant Dengue Myocarditis Treated with Venoarterial Extracorporeal Membrane Oxygenation: A Report of Four Cases
Dengue disease is found worldwide and has been spreading exponentially in the past decades. Severe forms affect about 2% of patients, sometimes leading to organ failure. Recent studies have shown that fulminant dengue myocarditis is more common than previously thought, and fatal cases have been reported. The treatment of fulminant dengue myocarditis remains supportive and is very challenging in cases of cardiogenic shock. Here, we describe four cases presenting with fulminant dengue myocarditis treated with extracorporeal membrane oxygenation, among two survived.
- 3 February 2021
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 104 (2) , 552-556
Case Report: Refractory Shock due to Fulminant Dengue Myocarditis Treated with Venoarterial Extracorporeal Membrane Oxygenation: A Report of Four Cases
Dengue disease is found worldwide and has been spreading exponentially in the past decades. Severe forms affect about 2% of patients, sometimes leading to organ failure. Recent studies have shown that fulminant dengue myocarditis is more common than previously thought, and fatal cases have been reported. The treatment of fulminant dengue myocarditis remains supportive and is very challenging in cases of cardiogenic shock. Here, we describe four cases presenting with fulminant dengue myocarditis treated with extracorporeal membrane oxygenation, among two survived.